In many cases, employer-sponsored health plans exclude weight-loss medications altogether, even when obesity-related conditions significantly impact overall health outcomes
Brenta G, Vaisman M, Sgarbi JA, Bergoglio LM, de Andrada NC, Bravo PP et al (2013) Clinical practice guidelines for the management of hypothyroidism
As more data emerge, clinicians may gain clearer insight into whether hemoglobin levels shift in specific high-risk populations
The researchers concluded that the current evidence is insufficient to support the use of FMT for IBS in routine clinical practice, highlighting the need to identify which patient populations might benefit and to establish standardized protocols
CPT Pharmacometrics & Systems Pharmacology, 13(3), pp.494503